期刊文献+

巨噬细胞移动抑制因子对结肠癌HT-29细胞增殖和血管生成因子表达的影响

Effects of macrophage migration inhibitory factor on the proliferation and expression of angiogenesis factor in human colon carcinoma cell HT-29
下载PDF
导出
摘要 目的研究巨噬细胞移动抑制因子(MIF)在体外对人结肠癌细胞HT-29增殖及VEGF和IL-8表达的影响。方法分别用25、50、100μg/L人重组MIF(rhMIF)对细胞进行处理后,采用MTT法检测细胞增殖,RT-PCR检测细胞VEGF、IL-8mRNA含量,ELISA测定细胞培养上清液中VEGF和IL-8的蛋白含量。结果rhMIF作用不同时间后,能够促进HT-29细胞生长,增殖活性随浓度增加、时间延长逐渐上升(P<0.05),呈现量—效、时—效关系。细胞VEGF和IL-8mRNA表达及上清液中VEGF和IL-8蛋白含量均明显增加,存在时间和浓度依赖性(P<0.05)。结论MIF能够促进结肠癌细胞增殖,MIF参与肿瘤血管形成有可能是通过上调VEGF和IL-8的表达发挥作用。 Objectives To investigate the effects of macrophage migration inhibitory factor on the proliferation and expression of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) in colon carcinoma cell train HT-29. Methods The cultured HT-29 cells were treated with different concentrations of recombinant human macrophage migration inhibitory factor (rhMIF)(25, 50, 100fig/L) for different time. The proliferation of HT-29 cells was detected by MTT assay. The expression of VEGF and IL-8 mRNA in HT-29 cells were examined by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) and the levels of VEGF and IL8 protein in the supernatants were determined by enzyme-linked immunosorbent assay (ELISA). Results RhMIF promoted the proliferation of HT-29 cells in a concentration- and time-dependent manner (P〈0.05), and the proliferating activity was increased with the raise of concentration and prolonging of action time. The expression of VEGF and IL-8 mRNA and the levels of VEGF and IL-8 protein in supernatants were increased gradually with the raise of concentration or action time (P〈0.05). Conclusions MIF promotes the proliferation of colon carcinoma cells, and MIF plays a crucial role in the angiogenesis of colon cancer and the roles of MIF may be realized via raising the expression of VEGF and IL-8.
出处 《国际消化病杂志》 CAS 2008年第6期515-519,共5页 International Journal of Digestive Diseases
关键词 巨噬细胞移动抑制因子 结肠癌 血管内皮生长因子 白细胞介素-8 Macrophage migration inhibitory factor Colon carcinoma Vascular endothelial growth factor Interleukin-8
  • 相关文献

参考文献11

  • 1Kubo F, Ueno S, Hiwatashi K, et al. Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis. Ann Surg Oncol, 2005, 12: 800-807.
  • 2Liao H, Bucala R, Mitchell RA, et al. Adhesion dependent signaling by macrophage migration inhibitory factor(MIF). J Biol Chem, 2003, 278: 76-81.
  • 3Nishihira J, Ishibashi T, Fukushima T, et al. Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci, 2003, 995:171- 182.
  • 4Hagemann T, Wilson J, Kulbe H, et al. Macrophages induce invasiveness of epithelial cancer cells via NF kappaB and JNK. J Immunol, 2005, 175:1197- 1205.
  • 5Ogawa H, Nishihira J, Sato Y, et al. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine, 2000, 12: 309-314.
  • 6李智,林素暇,梁惠珍,梁英杰,何洁华.巨噬细胞移动抑制因子与鼻咽癌微血管生成和淋巴结转移的关系[J].中山大学学报(医学科学版),2005,26(1):24-28. 被引量:15
  • 7Ren Y, Law S, Huang X, et al. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node ststus in patients with esophageal squamous cell carcinoma. Ann Surg, 2005, 242 : 55- 63.
  • 8Albertsson P, Lennernas B, Norrby K, et al. Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A. Acta Oncol, 2008, 47:293-300.
  • 9Yuan A, Chang Chen, Huang HT, et al. Biologic effects of four VEGF isoforms on the in vivo vascular perfusion and morphology of tumor-associated angiogenesis in non-small cell lung cancer-evaluated by MRI. Proc Amer Assoc Cancer Res, 2006, 47: 443-450.
  • 10刘强,陈卫昌,傅建新,康苏娅.大肠癌组织中血管生成与凋亡、增殖的关系[J].中华消化杂志,2004,24(7):418-421. 被引量:5

二级参考文献15

  • 1Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene, 2000,19:6122-6129.
  • 2Grunstein J, Roberts WG, Mathieu-Costello O, et al. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res,1999,59:1592-1598.
  • 3Bruns CJ, Liu W, Davis DW, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer,2000,89: 488-499.
  • 4Jackson MW, Roberts JS, Heckford SE, et al. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res, 2002,62: 854-859.
  • 5Kondo Y, Arii S, Furutani M,et al. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive cotorectal carcinoma. Cancer, 2000, 88:1820-1827.
  • 6Ishigami SI,Arii S, Furutani M, et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer, 1998, 78:1379-1384.
  • 7Tanigawa N, Amaya H, Matsumura M, et al. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res, 1997,57: 1043-1046.
  • 8Katoh O,Takahashi T, Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL 1 acting as an antiapoptotic factor. Cancer Res, 1998,58: 5565-5569.
  • 9Tran J, Rak J, Sheehan C, et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun, 1999,264:781-788.
  • 10李智,宗永生.鼻咽癌组织中潜伏膜蛋白1的表达对癌细胞增殖和凋亡的影响[J].中华病理学杂志,1999,28(5):340-343. 被引量:15

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部